Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Research

Analysis of cells of epithelial, connective tissue and immune differentiation in HPV-positive-, HPV-negative oropharyngeal carcinoma and normal oropharyngeal tissue by immunofluorescence multiplex image cytometry: a preliminary report

Authors: Aris I. Giotakis, Annette Runge, József Dudas, Rudolf Glueckert, Timo Gottfried, Volker H. Schartinger, Johanna Klarer, Avneet Randhawa, Eleonora Caimmi, Herbert Riechelmann

Published in: BMC Cancer | Issue 1/2023

Login to get access

Abstract

Background

Epithelial, connective tissue and immune cells contribute in various ways to the pathophysiology of HPV positive (HPV+) and HPV negative (HPV-) oropharyngeal squamous cell carcinoma (OPSCC). We aimed to investigate the abundance of these cell lineages and their coexpression patterns in patients with HPV + and HPV- OPSCC.

Methods

We used a 4-channel immunofluorescence-microscopy technique for the simultaneous detection of three direct-conjugated antibodies (pancytokeratin, vimentin and CD45/CD18) and DAPI (4’,6-Diamidin-2-phenylindole) in formalin fixed paraffin-embedded tissue samples (FFPE) of patients with HPV + and HPV- OPSCC, and of control patients. Image acquisition and analysis were performed with TissueFAXS and StrataQuest (TissueGnostics, Vienna, Austria), respectively, in tumor cell clusters/stroma in OPSCC specimens and epithelial layer/lamina propria in control specimens. Cell populations were created based on antibodies’ coexpression patterns. Isotype and positive controls were examined for plausibility.

Results

The proportion of cells of epithelial differentiation in tumor cell clusters was higher in HPV + OPSCC (55%) than in HPV- OPSCC samples (44%). The proportion of connective tissue cells in tumor cell cluster was lower in HPV + OPSCC patients (18%) than in HPV- OPSCC patients (26%). The proportion of immune cells in tumor cell clusters was higher in HPV + OPSCC patients (25%) than in HPV- OPSCC patients (18%). The percentage of anaplastic, potentially de-differentiated cells, was 2% in control patients, and it was higher in HPV- OPSCC (21%) than in HPV + OPSCC samples (6%).

Conclusions

This study provided the first quantitative data for the abundance of cells of epithelial, connective tissue and immune differentiation, in patients with OPSCC and control patients. The abundance of these different crucial cell populations was consistently originating from the same tissue sample. De-differentiation of tumor cells was higher in HPV- OPSCC than in HPV + OPSCC. In tumor cells clusters, the antitumoral host immune response was higher in HPV + OPSCC than in HPV- OPSCC, whereas the fibroblast response was higher in HPV- OPSCC than in HPV + OPSCC. This study contributed to the understanding of histopathologic differences between HPV + OPSCC and HPV- OPSCC patients.
Appendix
Available only for authorised users
Literature
1.
Pezzuto F, Buonaguro L, Caponigro F, Ionna F, Starita N, Annunziata C, Buonaguro FM, Tornesello ML. Update on Head and Neck Cancer: current knowledge on epidemiology, risk factors, molecular features and Novel Therapies. Oncology. 2015;89(3):125–36.PubMedCrossRef
2.
van Monsjou HS, van Velthuysen ML, van den Brekel MW, Jordanova ES, Melief CJ, Balm AJ. Human papillomavirus status in young patients with head and neck squamous cell carcinoma. Int J Cancer. 2012;130(8):1806–12.PubMedCrossRef
3.
Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24–35.PubMedPubMedCentralCrossRef
4.
Licitra L, Perrone F, Bossi P, Suardi S, Mariani L, Artusi R, Oggionni M, Rossini C, Cantu G, Squadrelli M, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol. 2006;24(36):5630–6.PubMedCrossRef
5.
Rietbergen MM, Brakenhoff RH, Bloemena E, Witte BI, Snijders PJ, Heideman DA, Boon D, Koljenovic S, Baatenburg-de Jong RJ, Leemans CR. Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment de-escalation trials. Ann Oncol. 2013;24(11):2740–5.PubMedCrossRef
6.
Wansom D, Light E, Worden F, Prince M, Urba S, Chepeha DB, Cordell K, Eisbruch A, Taylor J, D’Silva N, et al. Correlation of cellular immunity with human papillomavirus 16 status and outcome in patients with advanced oropharyngeal cancer. Arch Otolaryngol Head Neck Surg. 2010;136(12):1267–73.PubMedPubMedCentralCrossRef
7.
Almangush A, Mäkitie AA, Triantafyllou A, de Bree R, Strojan P, Rinaldo A, Hernandez-Prera JC, Suárez C, Kowalski LP, Ferlito A, et al. Staging and grading of oral squamous cell carcinoma: an update. Oral Oncol. 2020;107:104799.PubMedCrossRef
8.
De Wever O, Demetter P, Mareel M, Bracke M. Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer. 2008;123(10):2229–38.PubMedCrossRef
9.
Bolt R, Foran B, Murdoch C, Lambert DW, Thomas S, Hunter KD. HPV-negative, but not HPV-positive, oropharyngeal carcinomas induce fibroblasts to support tumour invasion through micro-environmental release of HGF and IL-6. Carcinogenesis. 2018;39(2):170–9.PubMedCrossRef
10.
11.
Senovilla L, Vacchelli E, Galon J, Adjemian S, Eggermont A, Fridman WH, Sautes-Fridman C, Ma Y, Tartour E, Zitvogel L, et al. Trial watch: prognostic and predictive value of the immune infiltrate in cancer. Oncoimmunology. 2012;1(8):1323–43.PubMedPubMedCentralCrossRef
12.
Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12(4):298–306.PubMedCrossRef
13.
Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology. 2002;40(5):403–39.PubMedCrossRef
14.
Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982;31(1):11–24.PubMedCrossRef
15.
Woods RSR, Keegan H, White C, Tewari P, Toner M, Kennedy S, O’Regan EM, Martin CM, Timon CVI, O’Leary JJ. Cytokeratin 7 in Oropharyngeal squamous cell carcinoma: a junctional biomarker for human papillomavirus-related tumors. Cancer Epidemiol Biomarkers Prev. 2017;26(5):702–10.PubMedCrossRef
16.
Morbini P, Capello GL, Alberizzi P, Benazzo M, Paglino C, Comoli P, Pedrazzoli P. Markers of squamocolumnar junction cells in normal tonsils and oropharyngeal cancer with and without HPV infection. Histol Histopathol. 2015;30(7):833–9.PubMed
17.
Regauer S, Beham A, Mannweiler S. CK7 expression in carcinomas of the Waldeyer’s ring area. Hum Pathol. 2000;31(9):1096–101.PubMedCrossRef
18.
Giotakis AI, Dudas J, Glueckert R, Dejaco D, Ingruber J, Fleischer F, Innerhofer V, Pinggera L, Bektic-Tadic L, Gabriel SAM, et al. Characterization of epithelial cells, connective tissue cells and immune cells in human upper airway mucosa by immunofluorescence multichannel image cytometry: a pilot study. Histochem Cell Biol. 2021;155(3):405–21.PubMedCrossRef
19.
Ecker RC, Rogojanu R, Streit M, Oesterreicher K, Steiner GE. An improved method for discrimination of cell populations in tissue sections using microscopy-based multicolor tissue cytometry. Cytometry A. 2006;69(3):119–23.PubMedCrossRef
20.
Ecker RC, Steiner GE. Microscopy-based multicolor tissue cytometry at the single-cell level. Cytometry A. 2004;59(2):182–90.PubMedCrossRef
21.
Healy S, McMahon J, Owens P, Dockery P, FitzGerald U. Threshold-based segmentation of fluorescent and chromogenic images of microglia, astrocytes and oligodendrocytes in FIJI. J Neurosci Methods. 2018;295:87–103.PubMedCrossRef
22.
Zanoni DK, Patel SG, Shah JP. Changes in the 8th Edition of the american Joint Committee on Cancer (AJCC) staging of Head and Neck Cancer: Rationale and Implications. Curr Oncol Rep 2019, 21(6).
23.
Runge A, Vales A, Pommer G, Raab H, Prossliner H, Randhawa A, Schennach H, Riechelmann H. Perioperative Blood Transfusion in Head and Neck Cancer Revisited. Laryngoscope. 2023;133(7):1638–44.PubMedCrossRef
24.
Lydiatt WM, Patel SG, O’Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, Loomis AM, Shah JP. Head and Neck cancers-major changes in the american Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):122–37.PubMedCrossRef
25.
Jiang L, Ji N, Zhou Y, Li J, Liu X, Wang Z, Chen Q, Zeng X. CAL 27 is an oral adenosquamous carcinoma cell line. Oral Oncol. 2009;45(11):e204–207.PubMedCrossRef
26.
Lechner M, Schartinger VH, Steele CD, Nei WL, Ooft ML, Schreiber LM, Pipinikas CP, Chung GT, Chan YY, Wu F, et al. Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy. Nat Commun. 2021;12(1):117.PubMedPubMedCentralCrossRef
27.
Mahanonda R, Sa-Ard-Iam N, Montreekachon P, Pimkhaokham A, Yongvanichit K, Fukuda MM, Pichyangkul S. IL-8 and IDO expression by human gingival fibroblasts via TLRs. J Immunol. 2007;178(2):1151–7.PubMedCrossRef
28.
Tarnowski BI, Spinale FG, Nicholson JH. DAPI as a useful stain for nuclear quantitation. Biotech Histochem. 1991;66(6):297–302.PubMedCrossRef
29.
Baba AI, Câtoi C. Tumor cell morphology. Comparative oncology. edn.: The Publishing House of the Romanian Academy; 2007.
30.
Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19(2):185–93.PubMedCrossRef
31.
Gibbons MD, Manne U, Carroll WR, Peters GE, Weiss HL, Grizzle WE. Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands. Laryngoscope. 2001;111(8):1373–8.PubMedCrossRef
32.
Channir HI, Kiss K, Rubek N, Andersen J, Georgsen JB, Rathje GS, Charabi BW, von Buchwald C, Lajer CB. Comparison of clinical, radiological and morphological features including the distribution of HPV E6/E7 oncogenes in resection specimens of oropharyngeal squamous cell carcinoma. Oral Oncol. 2018;78:163–70.PubMedCrossRef
33.
Tosi A, Parisatto B, Menegaldo A, Spinato G, Guido M, Del Mistro A, Bussani R, Zanconati F, Tofanelli M, Tirelli G, et al. The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naive tumors with immune checkpoint inhibitors. J Exp Clin Cancer Res. 2022;41(1):279.PubMedPubMedCentralCrossRef
34.
Almangush A, Jouhi L, Haglund C, Hagstrom J, Makitie AA, Leivo I. Tumor-stroma ratio is a promising prognostic classifier in oropharyngeal cancer. Hum Pathol. 2023;136:16–24.PubMedCrossRef
35.
Santoro A, Pannone G, Ninivaggi R, Petruzzi M, Santarelli A, Russo GM, Lepore S, Pietrafesa M, Laurenzana I, Leonardi R, et al. Relationship between CK19 expression, deregulation of normal keratinocyte differentiation pattern and high risk-human papilloma virus infection in oral and oropharyngeal squamous cell carcinoma. Infect Agent Cancer. 2015;10:46.PubMedPubMedCentralCrossRef
36.
Regenbogen E, Mo M, Romeiser J, Shroyer ALW, Escobar-Hoyos LF, Burke S, Shroyer KR. Elevated expression of keratin 17 in oropharyngeal squamous cell carcinoma is associated with decreased survival. Head Neck. 2018;40(8):1788–98.PubMedCrossRef
37.
Rahrotaban S, Mahdavi N, Abdollahi A, Yazdani F, Kaghazloo A, Derakhshan S. Carcinoma-associated fibroblasts are a common finding in the Microenvironment of HPV-positive Oropharyngeal squamous cell carcinoma. Appl Immunohistochem Mol Morphol. 2019;27(9):683–8.PubMedCrossRef
38.
Mohamed H, Haglund C, Jouhi L, Atula T, Hagstrom J, Makitie A. Expression and role of E-Cadherin, beta-catenin, and vimentin in human papillomavirus-positive and human papillomavirus-negative Oropharyngeal squamous cell carcinoma. J Histochem Cytochem. 2020;68(9):595–606.PubMedCrossRef
39.
Matlung SE, van Wilhelmina PM, Bovenschen N, van Baarle D, Willems SM. Differences in T-cell infiltrates and survival between HPV + and HPV- oropharyngeal squamous cell carcinoma. Future Sci OA. 2016;2(1):FSO88.PubMedPubMedCentralCrossRef
40.
De Meulenaere A, Vermassen T, Aspeslagh S, Deron P, Duprez F, Laukens D, Van Dorpe J, Ferdinande L, Rottey S. Tumor PD-L1 status and CD8(+) tumor-infiltrating T cells: markers of improved prognosis in oropharyngeal cancer. Oncotarget. 2017;8(46):80443–52.PubMedPubMedCentralCrossRef
41.
De Meulenaere A, Vermassen T, Aspeslagh S, Zwaenepoel K, Deron P, Duprez F, Rottey S, Ferdinande L. Prognostic markers in oropharyngeal squamous cell carcinoma: focus on CD70 and tumour infiltrating lymphocytes. Pathology. 2017;49(4):397–404.PubMedCrossRef
42.
Wuerdemann N, Gultekin SE, Putz K, Wittekindt C, Huebbers CU, Sharma SJ, Eckel H, Schubotz AB, Gattenlohner S, Buttner R et al. PD-L1 expression and a high Tumor infiltrate of CD8 + lymphocytes predict outcome in patients with Oropharyngeal squamous cells Carcinoma. Int J Mol Sci 2020, 21(15).
43.
Kemnade JO, Elhalawani H, Castro P, Yu J, Lai S, Ittmann M, Mohamed ASR, Lai SY, Fuller CD, Sikora AG, et al. CD8 infiltration is associated with disease control and tobacco exposure in intermediate-risk oropharyngeal cancer. Sci Rep. 2020;10(1):243.PubMedPubMedCentralCrossRef
44.
Lechien JR, Descamps G, Seminerio I, Furgiuele S, Dequanter D, Mouawad F, Badoual C, Journe F, Saussez S. HPV involvement in the Tumor Microenvironment and Immune Treatment in Head and Neck squamous cell carcinomas. Cancers (Basel) 2020, 12(5).
45.
Hatakeyama H, Mizumachi T, Sakashita T, Kano S, Homma A, Fukuda S. Epithelial-mesenchymal transition in human papillomavirus-positive and -negative oropharyngeal squamous cell carcinoma. Oncol Rep. 2014;32(6):2673–9.PubMedCrossRef
46.
Lefevre M, Rousseau A, Rayon T, Dalstein V, Clavel C, Beby-Defaux A, Pretet JL, Soussan P, Polette M, Lacau Saint Guily J, et al. Epithelial to mesenchymal transition and HPV infection in squamous cell oropharyngeal carcinomas: the papillophar study. Br J Cancer. 2017;116(3):362–9.PubMedPubMedCentralCrossRef
47.
Toki MI, Cecchi F, Hembrough T, Syrigos KN, Rimm DL. Proof of the quantitative potential of immunofluorescence by mass spectrometry. Lab Invest. 2017;97(3):329–34.PubMedPubMedCentralCrossRef
48.
49.
Nakanishi Y, Ochiai A, Kato H, Tachimori Y, Igaki H, Hirohashi S. Clinicopathological significance of tumor nest configuration in patients with esophageal squamous cell carcinoma. Cancer. 2001;91(6):1114–20.PubMedCrossRef
50.
Crissman JD, Liu WY, Gluckman JL, Cummings G. Prognostic value of histopathologic parameters in squamous cell carcinoma of the oropharynx. Cancer. 1984;54(12):2995–3001.PubMedCrossRef
51.
Li X, Li C, Zhu G, Yuan W, Xiao ZA. TGF-beta1 induces epithelial-mesenchymal transition of chronic sinusitis with nasal polyps through MicroRNA-21. Int Arch Allergy Immunol. 2019;179(4):304–19.PubMedCrossRef
52.
Almangush A, Alabi RO, Troiano G, Coletta RD, Salo T, Pirinen M, Makitie AA, Leivo I. Clinical significance of tumor-stroma ratio in head and neck cancer: a systematic review and meta-analysis. BMC Cancer. 2021;21(1):480.PubMedPubMedCentralCrossRef
53.
Karpathiou G, Vieville M, Gavid M, Camy F, Dumollard JM, Magne N, Froudarakis M, Prades JM, Peoc’h M. Prognostic significance of tumor budding, tumor-stroma ratio, cell nests size, and stroma type in laryngeal and pharyngeal squamous cell carcinomas. Head Neck. 2019;41(6):1918–27.PubMedCrossRef
54.
Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Reviews Disease Primers. 2020;6(1):92.PubMedCrossRef
Metadata
Title
Analysis of cells of epithelial, connective tissue and immune differentiation in HPV-positive-, HPV-negative oropharyngeal carcinoma and normal oropharyngeal tissue by immunofluorescence multiplex image cytometry: a preliminary report
Authors
Aris I. Giotakis
Annette Runge
József Dudas
Rudolf Glueckert
Timo Gottfried
Volker H. Schartinger
Johanna Klarer
Avneet Randhawa
Eleonora Caimmi
Herbert Riechelmann
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-11440-x

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue

Research

A novel PEGylated form of granulocyte colony-stimulating factor, mecapegfilgrastim, for peripheral blood stem cell mobilization in patients with hematologic malignancies

Study Protocol

Protocol for the SEHNeCa randomised clinical trial assesing Supervised Exercise for Head and Neck Cancer patients

Research

Preoperative serum bilirubin is an independent prognostic factor for curatively resected esophageal squamous cell carcinoma

Research

Single-copy Snail upregulation causes partial epithelial-mesenchymal transition in colon cancer cells

Correction

Correction: Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients

Study protocol

Assessment of Autologous Blood marker localIzation and intraoperative coLonoscopy localIzation in laparoscopic colorecTal cancer surgery (ABILITY): a randomized controlled trial
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits